How did Eden Brew come about?
Eden Brew is a ‘Company Creation’ model, co-founded by CSIRO, Norco Dairies, Main Sequence Ventures and Jim Fader, a career FMCG executive. We have combined CSIRO’s deep-tech know how based on years of research into precision fermented caseins and the casein micelle, with Main Sequence’s deep tech investment approach, Norco’s supply chain & dairy manufacturing capability and Jim Fader’s entrepreneurial leadership and food product development experience.
What is your “why”?
Unfortunately, today, it is difficult to eat well all the time. Food systems deliver more calories, but nutrient quality is declining. Nutrient-rich foods can be unaffordable or inaccessible for many. Supplementation is inconsistent and often poorly absorbed. Climate shocks are reducing yields and reliability and increasing costs.
Lancet Global Health Report 2022
Over 5 billion people are deficient in at least one of Iron, Magnesium, Zinc, Folate, Vitamin A & Vitamin D, leading to many health and lifestyle challenges.
Dairy is synonymous with health & nutrition. The casein micelle is natures slow-release delivery system. A bit like with cheese making, when you consume casein micelles, they form a curd in your stomach which takes 5 hours to digest. The ‘glue’ in the curd is calcium, which is released as the curd breaks down. This slow-release system is nature's design for feeding calcium to a baby’s fast-growing bones. Eden Brew builds these micelles and, in addition to calcium, loads them with iron, magnesium, and zinc, creating a range of curated B2B ingredients for supplements, sports nutrition and food fortification. Our novel and flexible protein powder ingredient drives bioavailability and can be used in many different foods to drive nutrient density and healthy eating.
What could Eden Brew achieve in the future?
Eden Brew will initially focus on unique approaches to iron and magnesium supplementation to assist with women’s health, healthy ageing, and GLP-1 companion foods for nutrition support. Through scale, Eden Brew will be able to manufacture casein proteins at price parity with the dairy industry by 2031. This will allow Eden Brew to sell B2B protein ingredients globally to CPG companies competitively and assist with the food system’s ability to scale climate friendly solutions to meet the forecast increase in global demand for protein of 50%+ by 2050, and always with the ability to supply nutrient dense, health focused ingredients.
Find out more about Breakthrough Victoria's investment in Eden Brew here .